Cancer cells express high levels of pyruvate dehydrogenase kinases (PDKs) to inhibit PDH, which is responsible for catalyzing the conversion of pyruvate to acetyl-CoA, which flows into the tricarboxylic acid (TCA) cycle (126). This evidence concerns the gene PDP1 and cancer.